EcoDrugPlus

Integrin Subunit Alpha 4

Ensembl ID : ENSMAUG00000016911
Gene Symbol: ITGA4
4 Cross references
236 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSMAUG00000017255
Gene Symbol: ITGA5
3 Cross references
269 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSMAUG00000015740
Gene Symbol: ITGAV
4 Cross references
243 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSMAUG00000015611
Gene Symbol: ITGB3
4 Cross references
265 Possible Orthologues:

Integrin Subunit Beta 7

Ensembl ID : ENSMAUG00000020375
Gene Symbol: ITGB7
4 Cross references
160 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSMAUG00000000108
Gene Symbol: ITGB8
4 Cross references
202 Possible Orthologues:

Intercellular Adhesion Molecule 1

Ensembl ID : ENSMAUG00000006369
Gene Symbol: ICAM1
3 Cross references
93 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSMAUG00000015813
Gene Symbol: IRAK4
4 Cross references
202 Possible Orthologues:

Interleukin 5

Ensembl ID : ENSMAUG00000009715
Gene Symbol: IL5
4 Cross references
91 Possible Orthologues:

Interleukin 6

Ensembl ID : ENSMAUG00000017531
Gene Symbol: IL6
4 Cross references
162 Possible Orthologues:

Interstitial Collagenase A

Ensembl ID : ENSMAUG00000009988
Gene Symbol: LOC101824185
2 Cross references
352 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSMAUG00000019935
Gene Symbol: IDH2
4 Cross references
261 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).